Divis Laboratories

BSE : 532488 | NSE : DIVISLAB

Industry : Pharma Drugs | ISIN : INE361B01024 | FreeFloat : 50.00% | FnO : Yes | LotSize : 200


Intellectual Capital (IC)24,720.84
Net Worth (NW)9,853.45
Intrinsic Worth (IW)34,574.29
Market Cap (MC)117,025.20
Economic Value Added265.85
Discount Rate%
Liquidity Premium%
Knowledge Basis (IC/IW)71.50%
IC Gross Margin (EBITDA/IC)13.04%
IC Net Margin (NPT/IC)8.69%
Knowledge Turnover (Sales/IC)0.31
Market to Intrinsic Value (MC/IW)3.38

As OfIntrinsic ValueMarket Price
30 Jun 2021Rs. 1,302.39Rs. 4,408.25
20 Sep 2021 ---- Rs. 5,110.10
-12.70     -0.25%
Fundamental - medium termTechnical - near termCombined outlook
EVA > 0 : YesBuy10 DMA : Rs. 5,129.39SellAvoid
KB > 50% : Yes50 DMA : Rs. 4,926.46
0 < M2IV < 1 : NoVol-Price trend : Falling

Question 3 - Is this stock undervalued?


Question 2 - Does this business have significant knowledge assets?


Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.

Quarterly Results (Rs. Cr)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Sep-18
S
1285.00
1365.05
594.18
551.79
551.55
397.65
397.82
Dec-18
S
1342.92
1377.48
557.89
515.41
512.89
379.49
379.65
Mar-19
S
1256.43
1298.16
452.82
410.48
410.38
289.35
289.90
Jun-19
S
1139.92
1171.55
410.24
366.43
366.11
267.35
267.65
Sep-19
S
1403.92
1451.28
532.72
486.81
483.02
352.83
353.09
Dec-19
S
1390.49
1430.80
537.18
490.49
488.94
360.73
360.91
Mar-20
S
1376.24
1452.76
525.16
475.62
475.22
391.80
385.85
Jun-20
S
1709.96
1727.83
716.85
660.88
660.70
492.25
492.00
Sep-20
S
1749.30
1762.94
754.78
693.65
693.49
519.59
521.35
Dec-20
S
1701.44
1720.76
710.53
642.35
642.08
470.62
471.20
Mar-21
S
1788.19
1811.71
739.78
669.70
669.49
502.02
499.63
Jun-21
S
1960.64
1996.61
888.02
814.76
814.48
557.11
558.84
* C - Consolidated, S - Standalone